Researchers in China have shown that adding measurements from computed bioconductance (CB) to fluorodeoxyglucose PET ( ¹⁸FDG-PET) imaging can work as a non-invasive, pre-biopsy option for accurately distinguishing between benign and malignant lesions in the lungs, according to a study abstract published ahead of presentation at an international thoracic specialist gathering. {read more here}